PubMed · 144039
Treatment of Paget's disease of bone with mithramycin.
Abstract
The hypothesis that Paget's disease of bone is a low grade neoplastic process led us to use the cytotoxic antibiotic mithramycin in its treatment. The dramatic effects observed on the serum calcium and alkaline phosphatase, and urinary hydroxyproline are compatible with the concept that mithramycin is primarily toxic to osteoclasts. Subjective and objective clinical effects establish this agent as useful in the treatment of Paget's disease despite its observed toxicity to other organ systems.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
W G Ryan. 1977. Treatment of Paget's disease of bone with mithramycin.. https://pubmed.ncbi.nlm.nih.gov/144039/
Cite the original work for its findings. Save a collection to share your selection of sources.